Market research
SYBX Synlogic Inc
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 15M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- Not available
- Beta
- 0.5
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US87166L1008
- Market cap
- 15M
- P/E ratio
- Not available
- Analyst target
- 1
- Dividend yield
- Not available
- Beta
- 0.5
About
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SYBX discussion.
5 years, 4 months ago
Synlogic, Inc is currently in a long term uptrend where the price is trading 19.2% above its 200 day moving average.
From a valuation standpoint, the stock is 82.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 237.4.
Synlogic, Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 100.0% to $0 since the same quarter in the previous year.
Finally, its free cash flow grew by 14.8% to $-10M since the same quarter in the previous year.
Based on the above factors, Synlogic, Inc gets an overall score of 4/5.